Beyond the Vaccine, Moderna Continues to Dazzle Investors

The COVID-19 pandemic has seen its presence linger, with increased viral circulation causing mutations and variants to spring up. These new strains have underlined and cemented the need for effective vaccines, and Moderna, Inc. (MRNA) is considered to be…

Click here to view the original article.